MyMD Pharmaceuticals Inc MYMD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:40 PM EDT
5.49quote price arrow down-0.24 (-4.19%)
Volume
6,263
Close
5.73quote price arrow up+0.40 (+7.50%)
Volume
608,735
52 week range
3.30 - 13.94

...

Loading . . .
  • Open5.18
  • Day High5.80
  • Day Low5.11
  • Prev Close5.33
  • 52 Week High13.94
  • 52 Week High Date08/10/20
  • 52 Week Low3.30
  • 52 Week Low Date05/17/21

Key Stats

  • Market Cap211.32M
  • Shares Out36.88M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change43.97

KEY STATS

  • Open5.18
  • Day High5.80
  • Day Low5.11
  • Prev Close5.33
  • 52 Week High13.94
  • 52 Week High Date08/10/20
  • 52 Week Low3.30
  • 52 Week Low Date05/17/21
  • Market Cap211.32M
  • Shares Out36.88M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change43.97

RATIOS/PROFITABILITY

  • EPS (TTM)-2.79
  • P/E (TTM)-2.05
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-10.217M
  • ROE (MRQ)-50.73%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-335.96%
  • Net Margin (MRQ)-13,049.39%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MyMD Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
MyMD Pharmaceuticals, Inc., formerly Akers Biosciences, Inc., is a clinical stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. MyMD-1 is being developed to...
Joshua Silverman
Chairman
Chris Chapman M.D.
President
Ian Rhodes CPA
Chief Financial Officer
Paul Rivard Esq., J.D.
Executive Vice President
Address
855 N. WOLFE STREET, SUITE 623
Baltimore, MD
21205
United States

Top Peers

SYMBOLLASTCHG%CHG
SINT
SINTX Technologies Inc
1.52+0.02+1.33%
BMRA
Biomerica Inc
3.85-0.21-5.17%
NBY
NovaBay Pharmaceuticals Inc
0.77+0.025+3.36%
ULUR
ULURU Inc
0.325-0.025-7.1429%
MLSS
Milestone Scientific Inc
1.98-0.08-3.88%
RMTI
Rockwell Medical Inc
0.9174UNCHUNCH